Site_Header_3.jpg

INANOTHERAD and THERADNET joint international conference

Organized by the research consortium THERADNET and the interdisciplinary center for cancer therapies based on radiations and nanoparticles: INANOTHERAD

 

 TOPICS

1.    New strategies to overcome radioresistance.
2.    New approaches related to the tumor microenvironment.
3.    AI-based strategies for personalized treatment.
4.    New sources & radiation modalities.
5.    Nanoparticles enhanced therapies in diagnosis and treatment.

This conference brings together international experts, researchers and students in radiotherapy and oncology, radiobiology, nanoscience and nanomedicine, medical physics, radiation chemistry and physics, development of radiation sources, to share ideas and formulate secure and personalized treatments of the future. 

This is at the heart of the ambitious projects of MSCA-ITN THERADNET and INANOTHERAD which promote innovative strategies based on irradiation by new sources (high-dose rate, high LET, spatially structured, plasma) and the addition of tumor targeted nano-agents and drugs to sensitize tumors and protect normal tissues from ionizing radiation. 

The conference will take place at University Paris-Saclay, one of the eight World Innovative Clusters(2013 MIT technology review). 

*This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860245 

    

-------------------

INVITED SPEAKERS
 
R. Berbeco, USA
R. Coppes, NL
S. Demaria, US
N. Foray FR
A. De La Lande, FR
L. Gizzi, IT
V. Malka, IL
K. Parodi, DE
E. Porcel, FR
Y. Prezado, FR
C. Robert, FR
R. Sun, FR
C. Truillet, FR
 
 
 
ORGANISATION COMMITTEE

G. Baldacchino, FR
E. Bourneuf, FR
L. Dubois,NL
P.-M. Girard, FR
E. Hamonou, FR
E. Hawkins, FR
V. Jendrossek, DE
H. Johannssen, CH
S. Lacombe, FR
J. Oehler, CH
C. Pouponnot, FR
M. Pruschy, CH
J. Santos Sousa, FR
O. Seksek, FR
A. Sesink, FR

 
Online user: 2 Privacy
Loading...